Alexandra Charrow

2.2k total citations
43 papers, 924 citations indexed

About

Alexandra Charrow is a scholar working on Dermatology, Surgery and Epidemiology. According to data from OpenAlex, Alexandra Charrow has authored 43 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Dermatology, 12 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Alexandra Charrow's work include Hidradenitis Suppurativa and Treatments (15 papers), Colorectal and Anal Carcinomas (9 papers) and Chemotherapy-related skin toxicity (6 papers). Alexandra Charrow is often cited by papers focused on Hidradenitis Suppurativa and Treatments (15 papers), Colorectal and Anal Carcinomas (9 papers) and Chemotherapy-related skin toxicity (6 papers). Alexandra Charrow collaborates with scholars based in United States, Australia and Canada. Alexandra Charrow's co-authors include Sarah Meyers-Ohki, Theresa S. Betancourt, Stephen S Lim, Christopher J L Murray, David B. Stein, Wietse A. Tol, Nathan B. Hansen, Arash Mostaghimi, Cara Joyce and Fan Xia and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Alexandra Charrow

32 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Charrow United States 12 244 179 162 141 138 43 924
Yasmin Jayasinghe Australia 25 159 0.7× 238 1.3× 223 1.4× 244 1.7× 89 0.6× 77 1.8k
Babatunde Adedokun Nigeria 21 207 0.8× 182 1.0× 195 1.2× 82 0.6× 24 0.2× 85 1.2k
Sandra Peláez Canada 15 191 0.8× 152 0.8× 97 0.6× 50 0.4× 46 0.3× 57 745
Sara E. Simonsen United States 23 127 0.5× 172 1.0× 279 1.7× 51 0.4× 28 0.2× 93 1.7k
David Muram United States 23 381 1.6× 140 0.8× 126 0.8× 155 1.1× 19 0.1× 136 1.8k
Sarah Creighton United Kingdom 41 264 1.1× 222 1.2× 308 1.9× 36 0.3× 28 0.2× 162 4.7k
Sara Thomas United Kingdom 15 62 0.3× 41 0.2× 348 2.1× 46 0.3× 47 0.3× 46 1.1k
John A. Webb United States 22 315 1.3× 301 1.7× 254 1.6× 53 0.4× 39 0.3× 46 1.1k
Margaret K. Formica United States 12 157 0.6× 117 0.7× 93 0.6× 115 0.8× 8 0.1× 25 737
Tina D. Cunningham United States 20 145 0.6× 196 1.1× 197 1.2× 18 0.1× 32 0.2× 57 1.3k

Countries citing papers authored by Alexandra Charrow

Since Specialization
Citations

This map shows the geographic impact of Alexandra Charrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Charrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Charrow more than expected).

Fields of papers citing papers by Alexandra Charrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Charrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Charrow. The network helps show where Alexandra Charrow may publish in the future.

Co-authorship network of co-authors of Alexandra Charrow

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Charrow. A scholar is included among the top collaborators of Alexandra Charrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Charrow. Alexandra Charrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shaw, Katharina S., Michael J. Murphy, William Damsky, et al.. (2025). Interleukin‐12/23 and Interleukin‐23 Inhibitors for the Treatment of Cutaneous Crohn's Disease: A Case Series From a Multi‐Institutional Registry. JEADV Clinical Practice. 4(2). 458–462.
2.
Charrow, Alexandra, et al.. (2025). Safety and efficacy of biologics in patients with Down syndrome and hidradenitis suppurativa: a retrospective cohort study. Clinical and Experimental Dermatology. 50(7). 1431–1433.
3.
Baker, Natalie & Alexandra Charrow. (2025). Climate Change and Dermatologic Health in People Experiencing Housing Instability and Homelessness. Dermatologic Clinics. 44(1). 89–104.
4.
Charrow, Alexandra, et al.. (2025). Noncutaneous Infections in Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study. JID Innovations. 5(3). 100349–100349.
5.
Charrow, Alexandra, et al.. (2024). Biologics in hidradenitis suppurativa: Progress and new directions. Journal of the American Academy of Dermatology. 91(6). S27–S30. 2 indexed citations
6.
7.
8.
Kwak, Ruby, et al.. (2022). Impact of isotretinoin on inflammatory bowel disease flare in patients with preexisting inflammatory bowel disease diagnosis: A cross-sectional study. Journal of the American Academy of Dermatology. 87(6). 1399–1400. 1 indexed citations
9.
Kwak, Ruby & Alexandra Charrow. (2020). 731 Risk of C. Difficile infection among hidradenitis suppurativa patients prescribed prolonged clindamycin course. Journal of Investigative Dermatology. 140(7). S98–S98.
10.
Thompson, Leah L., Steven T. Chen, Andrew J. Lawton, & Alexandra Charrow. (2020). Palliative care in dermatology: A clinical primer, review of the literature, and needs assessment. Journal of the American Academy of Dermatology. 85(3). 708–717. 4 indexed citations
11.
Savage, Kevin T., et al.. (2020). Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients. JAAD Case Reports. 6(2). 99–102. 42 indexed citations
12.
Kumar, Sandeep, et al.. (2020). Psoriasis: Knowledge, attitudes and perceptions among primary care providers. Journal of the American Academy of Dermatology. 84(5). 1421–1423. 4 indexed citations
13.
Charrow, Alexandra, et al.. (2019). Case Series: Minocycline-Associated Thyroiditis. Hormone Research in Paediatrics. 92(4). 276–283. 6 indexed citations
14.
Charrow, Alexandra, et al.. (2019). Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era. PLoS ONE. 14(3). e0210445–e0210445. 19 indexed citations
15.
Yerramilli, Divya, Alexandra Charrow, & Arthur L. Caplan. (2018). How Should Clinicians Respond When Patients Are Influenced by Celebrities' Cancer Stories?. The AMA Journal of Ethic. 20(11). E1075–1081. 1 indexed citations
16.
Charrow, Alexandra, Sotonye Imadojemu, Sasha Stephen, et al.. (2016). Cutaneous manifestations of IgG4-related disease (RD): A systematic review. Journal of the American Academy of Dermatology. 75(1). 197–202. 21 indexed citations
17.
Betancourt, Theresa S., Sarah Meyers-Ohki, Alexandra Charrow, & Wietse A. Tol. (2013). Interventions for Children Affected by War. Harvard Review of Psychiatry. 21(2). 70–91. 174 indexed citations
18.
Betancourt, Theresa S., Sarah Meyers-Ohki, Alexandra Charrow, & Nathan B. Hansen. (2012). Annual Research Review: Mental health and resilience in HIV/AIDS‐affected children – a review of the literature and recommendations for future research. Journal of Child Psychology and Psychiatry. 54(4). 423–444. 150 indexed citations
19.
Lim, Stephen S, David B. Stein, Alexandra Charrow, & Christopher J L Murray. (2008). Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. The Lancet. 372(9655). 2031–2046. 221 indexed citations
20.
Zeng, Weihua, Guibin Chen, Sachiko Kajigaya, et al.. (2003). Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers. Blood. 103(1). 325–332. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasmin Jayasinghe Breakdown of academic impact, for papers by Babatunde Adedokun Breakdown of academic impact, for papers by Sandra Peláez Breakdown of academic impact, for papers by Sara E. Simonsen Breakdown of academic impact, for papers by David Muram Breakdown of academic impact, for papers by Sarah Creighton Breakdown of academic impact, for papers by Sara Thomas Breakdown of academic impact, for papers by John A. Webb Breakdown of academic impact, for papers by Margaret K. Formica Breakdown of academic impact, for papers by Tina D. Cunningham
Rankless by CCL
2026